The AOM/DSS CRC model is colitis-associated carcinoma, so we choose low dose lysates (lysates of 5 × 105 CFU L. acidophilus) combined with CTLA-4 antibody. The gene discussed is CTLA4; the disease is colorectal carcinoma.